Allianz Asset Management
PCVX icon

Allianz Asset Management’s Vaxcyte PCVX Stock Holding History

Allianz Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$413K Hold
7,100
– – ﹤0.01% 1863
2025
Q4 		$328K Buy
+7,100
New +$318K ﹤0.01% 1885
2025
Q2 		– Sell
-6,800
Closed -$257K – 2230
2025
Q1 		$257K Hold
6,800
– – ﹤0.01% 2077
2024
Q4 		$557K Sell
6,800
-700
-9% -$69.5K ﹤0.01% 1828
2024
Q3 		$857K Hold
7,500
– – ﹤0.01% 1684
2024
Q2 		$566K Hold
7,500
– – ﹤0.01% 1790
2024
Q1 		$512K Sell
7,500
-2,500
-25% -$173K ﹤0.01% 1616
2023
Q4 		$628K Buy
10,000
+1,500
+18% +$77.9K ﹤0.01% 1777
2023
Q3 		$433K Buy
+8,500
New +$419K ﹤0.01% 1977

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return